Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FYI - updated corp presentation dated Sept 2021

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Sep 05, 2021 2:08pm

236 Views

Post# 33815689

RE:RE:RE:FYI - updated corp presentation dated Sept 2021

I'm no expert but from what I've read, there are many cell culture lines for different cancers. You can make them grow in a lab dish. You can measure the cell activity using markers or cell number or mass. If you test an intervention, you always have the exact same cells as a control comparison in an untreated dish.

Other ways to test are to have rodents with transplanted human tumours growing on them.

There is some interesting research in recent years showing that cancers don't behave in people quite the way they behave in dishes. A good response in a dish is a good starting point for sure.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports